XTL Biopharmaceuticals Ltd Sustainability Reports
XTL Biopharmaceuticals Ltd. is a biopharmaceutical platform company focused on the acquisition and development of medical therapies. It primarily targets autoimmune diseases like Lupus, and has recently expanded into psychedelic-based medicines for severe mental health disorders.
Sector: Manufacturing
Country: Israel
Exchange: Tel Aviv Stock Exchange
LEI: 529900NDDXEAPTUTXP41
FIGI: BBG001SG2ZW6
1 reports from 2024 to 2024